Literature DB >> 25726628

Evaluation of histologic features with potential prognostic value in ulcerative colitis.

Cristiana Popp, Florica Stăniceanu, Gianina Micu, Luciana Nichita, Mirela Cioplea, R B Mateescu, Th Voiosu, Liana Sticlaru.   

Abstract

Inflammatory bowel diseases (IBD) are a complex, heterogeneous, idiopathic, inflammatory, chronic entity with common clinical, endoscopical and histological features including some well-defined diseases (UC and CD), but also a group of indeterminate colitis. Ulcerative colitis is the most frequent and prominent member of IBD. The current study is trying to evaluate the impact of various histologic features on UC's evolution and outcome--an issue that has generated considerable interest in the academical environment. We gathered a cohort of 20 consecutive patients with positive clinical, endoscopical, histologic and imagistic diagnosis of UC who were prospectively enrolled for close clinical, biochemical, endoscopic and histologic surveillance. Every patient underwent an ileo-colonoscopy and multiple biopsies were taken from inflamed and normal areas of the mucosa. All these procedures were repeated after a year (12 months) of follow-up. This study is presenting the correlation between Mayo score for assessment of ulcerative colitis activity and several histologic features: Geboes histologic score for ulcerative colitis, basal plasmacytosis and vascular lesions using Pearson correlation test. The most promising prognosis value has basal plasmacytosis, confirming previous studies. These data emphasize the need of a more complex, clinical, endoscopic and histologic system of semi-quantitative assessment of UC lesions in order to stratify patients according to their risk to relapse.

Entities:  

Mesh:

Year:  2014        PMID: 25726628

Source DB:  PubMed          Journal:  Rom J Intern Med        ISSN: 1220-4749


  3 in total

Review 1.  Histologic scoring indices for evaluation of disease activity in ulcerative colitis.

Authors:  Mahmoud H Mosli; Claire E Parker; Sigrid A Nelson; Kenneth A Baker; John K MacDonald; G Y Zou; Brian G Feagan; Reena Khanna; Barrett G Levesque; Vipul Jairath
Journal:  Cochrane Database Syst Rev       Date:  2017-05-25

Review 2.  How to predict clinical relapse in inflammatory bowel disease patients.

Authors:  Elisa Liverani; Eleonora Scaioli; Richard John Digby; Matteo Bellanova; Andrea Belluzzi
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

3.  Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.

Authors:  Catarina Geraldes de Frias Gomes; Alexandra Sofia Ribeiro de Almeida; Catarina Callé Lucas Mendes; Pierre Ellul; Johan Burisch; Tiffany Buhagiar; Abigail Attard; Bobby Lo; Ryan C Ungaro; Bárbara Tonilhas da Silva Morão; Catarina Ferreira Gouveia; Joana Milheiro Delgado de Carvalho E Branco; Jaime Manuel Martins Pereira Rodrigues; Cristina Teixeira; Maria Francisca Faria Dias de Castro; Gonçalo Filipe Domingos Nunes; Mariana Brito; Marília Cristina de Sousa Antunes; Paula Maria Ferreira Brinca Borralho Nunes; Joana Maria Tinoco da Silva Torres
Journal:  Inflamm Bowel Dis       Date:  2022-03-02       Impact factor: 7.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.